AbCellera to Present Virtually at Berenberg Conference on May 18, 2021

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) has announced that its executives will present virtually at the Berenberg Conference USA 2021 on May 18, 2021, at 11:00 a.m. Pacific Time. A live audio webcast will be available through AbCellera’s Investor Relations website, with a replay accessible afterward.

AbCellera is a technology company focused on analyzing natural immune systems to discover antibodies for drug development. The company supports both large pharmaceutical and small biotechnology partners, enabling efficient and cost-effective drug development.

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the Berenberg Conference USA 2021 on Tuesday, May 18, 2021 at 11:00 a.m. Pacific Time.

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. To learn more, please visit us at www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210511006146/en/

FAQ

When will AbCellera present at the Berenberg Conference USA 2021?

AbCellera will present virtually at the Berenberg Conference USA 2021 on May 18, 2021, at 11:00 a.m. Pacific Time.

How can I access the AbCellera conference presentation?

You can access the live audio webcast of AbCellera's presentation through their Investor Relations website.

What is the focus of AbCellera's business?

AbCellera specializes in searching, decoding, and analyzing natural immune systems to identify antibodies for drug development.

What types of companies does AbCellera partner with?

AbCellera partners with both large pharmaceutical companies and small biotechnology firms to enhance drug development efforts.

Is there a replay available for the AbCellera presentation?

Yes, a replay of AbCellera's presentation will be available on their Investor Relations website following the live event.